These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

107 related items for PubMed ID: 2935965

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Mechanism of low-molecular-weight heparin reversal by platelet factor 4.
    Fiore MM, Mackie IM.
    Thromb Res; 2009 May; 124(1):149-55. PubMed ID: 19195682
    [Abstract] [Full Text] [Related]

  • 9. Pharmacokinetics of new synthetic heparin mimetics.
    Hérault JP, Bernat A, Roye F, Michaux C, Schaeffer P, Bono F, Petitou M, Herbert JM.
    Thromb Haemost; 2002 Jun; 87(6):985-9. PubMed ID: 12083506
    [Abstract] [Full Text] [Related]

  • 10. Characterization of human recombinant interleukin 2 binding to heparin and heparan sulfate using an ELISA approach.
    Najjam S, Gibbs RV, Gordon MY, Rider CC.
    Cytokine; 1997 Dec; 9(12):1013-22. PubMed ID: 9417813
    [Abstract] [Full Text] [Related]

  • 11. Structure-function relations of antithrombin III-heparin interactions as assessed by biophysical and biological assays and molecular modeling of peptide-pentasaccharide-docked complexes.
    Tyler-Cross R, Sobel M, McAdory LE, Harris RB.
    Arch Biochem Biophys; 1996 Oct 15; 334(2):206-13. PubMed ID: 8900394
    [Abstract] [Full Text] [Related]

  • 12. Anticoagulant mechanisms of Orgaran (Org 10172) and its fraction with high affinity to antithrombin III (Org 10849).
    Ofosu FA.
    Haemostasis; 1992 Oct 15; 22(2):66-72. PubMed ID: 1379966
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Heparin-induced thrombocytopenia: a stoichiometry-based model to explain the differing immunogenicities of unfractionated heparin, low-molecular-weight heparin, and fondaparinux in different clinical settings.
    Greinacher A, Alban S, Omer-Adam MA, Weitschies W, Warkentin TE.
    Thromb Res; 2008 Oct 15; 122(2):211-20. PubMed ID: 18262226
    [Abstract] [Full Text] [Related]

  • 15. Studies of heparin binding to antithrombin III by crossed immunoelectrophoresis.
    Barrowcliffe TW.
    Thromb Haemost; 1980 Feb 29; 42(5):1434-45. PubMed ID: 7368150
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.